CCL Products (India) Ltd Q2 FY27 results are out (Jul–Sep 2026) →See revenue, profit and what management said. You are viewing Q1 FY27.
CP

CCL Products (India) Ltd

Q1 FY27

CCL Products (India) Q1 FY27 earnings call: Revenue & Margins

Q1 FY27 earnings call: what management said on revenue, margins and capex.

What the Q1 FY27 call signalled

1 of 3 strong

RevenueModerate growth
MarginMargins steady
CapexCapex planned
Price₹1,008
Market cap₹13.5K Cr
P/E31.1

The short version

The company targets a volume growth of around 15% per annum for the next 3 to 5 years, maintaining strong growth momentum. The company targets a 15% volume growth annually for the next 3-5 years, with EBITDA growth expected to follow this trajectory.

From CCL Products (India) Ltd's Q1 FY27 earnings-call transcript · updated 16 Oct 2026.

Revenue & Sales Performance

Moderate growth
  • The company targets a volume growth of around 15% per annum for the next 3 to 5 years, maintaining strong growth momentum.
  • Q1 volume growth was 20%, exceeding the guidance, but management maintains the 15% guidance due to market volatility.
  • Sales growth is expected to follow volume growth, implying a similar percentage increase in EBITDA.
  • Domestic branded business is growing aggressively, with 20-25% volume growth expected in the current year.
  • Capacity utilization is currently around 75%; new capacity additions will be considered once utilization exceeds 75%, typically around 85-90%.
  • No major capex planned for next 2-3 years; existing capacity is sufficient to support growth.

2 more points from CCL Products (India) Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

The company targets a 15% volume growth annually for the next 3-5 years, with EBITDA growth expected to…

Locked: what CCL Products (India) Ltd said on margins

Also locked on this page: fundraising

Free account, 30 seconds. No card needed.

Capital Expenditure Plans

Capex planned
  • No major capex expansion planned in the next 2-3 years; current capacity is sufficient for growth.
  • Discussions on freeze-dried coffee capacity expansion exist but no firm capex planned due to high investment and need for sustained demand.
  • FY27 capex budget is INR25-50 crores, mainly for upgrades and small additions, not large expansions.
  • Capacity expansions are typically considered when utilization crosses 75-85%, with about 9-12 months gestation; currently, no immediate plans.
  • The company is exploring acquisition opportunities selectively, focusing on businesses where it can leverage its marketing and omni-channel distribution strength.

2 more points from CCL Products (India) Ltd's call on capex

Create a free account to keep reading this call

Fundraising & Capital Structure

Management emphasized focus on debt reduction and deleveraging; net debt reduced from INR1,268 crores…

Locked: what CCL Products (India) Ltd said on fundraising

Also locked on this page: margins

Free account, 30 seconds. No card needed.

Order Book & Pipeline

Relevant insights include: - The company achieved strong volume growth of 20% in Q1 FY27 and maintains a guidance of 15% volume growth for the full year, indicating healthy demand. - They emphasize consistent market share gains and expanding distribution in domestic branded business and internationally.

2 more points from CCL Products (India) Ltd's call on order book

Create a free account to keep reading this call

CCL Products (India) Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.2K Cr, net profit ₹115 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Agricultural Food & other Products this season

  • Sayaji Industr (Q1 FY27)

    Revenue from Operations for Q1FY27: ₹288 crore . Key investor presentation takeaways from Sayaji Industries Ltd's Q1 FY27 investor presentation — and how it ran

  • Sanstar (Q1 FY27)

    2,062 million, up 21.5% YoY from Rs. Key investor presentation takeaways from Sanstar Ltd's Q1 FY27 investor presentation — and how it ranks against sector peer

  • Uttam Sugar Mills (Q1 FY27)

    588.46 Cr vs Rs. Key investor presentation takeaways from Uttam Sugar Mills Ltd's Q1 FY27 investor presentation — and how it ranks against sector peers.

  • NFP Sampoorna (Q1 FY27)

    FY26 revenue grew 43% to INR 51 crore from INR 35 crore in FY25, driven by better capacity utilization and portfolio diversification. Key concall takeaways…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

CCL Products (India) Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were CCL Products (India) Ltd Q1 FY27 results?

The company targets a volume growth of around 15% per annum for the next 3 to 5 years, maintaining strong growth momentum. The company targets a 15% volume growth annually for the next 3-5 years, with EBITDA growth expected to follow this trajectory.

What is CCL Products (India) Ltd share price analysis?

CCL Products (India) Ltd currently shows a below-average growth signal. The stock trades at a P/E of 31.1 with a market cap of ₹13,464 Cr. Investors should review the full earnings analysis for detailed insights.

Is CCL Products (India) Ltd planning capital expenditure?

No major capex expansion planned in the next 2-3 years; current capacity is sufficient for growth.

Keep CCL Products (India) Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.